Log In
Print this Print this

VAL-017 (formerly 4s3-005)

  Manage Alerts
Collapse Summary General Information
Company Valerion Therapeutics LLC
DescriptionFusion protein of the delivery antibody 3E10 linked to a glycogen debrancher enzyme (GDE)
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Fusion protein
Latest Stage of DevelopmentDiscovery
Standard IndicationGlycosphingolipid storage disorders
Indication DetailsTreat Cori disease
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today